Accounting reportsPreviously
|
Name | SOLYUR-FARMA, OOO |
|---|
INN | 7702788201 |
|---|
KPP | 772301001 |
|---|
OGRN | 1127746324243 |
|---|
OKPO | 9282371 |
|---|
Address | 115088, G.Moskva, proezd. 3-y ugreshskiy, d. 6 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 20.42 | Additional activity | Manufacture of perfumes and cosmetics | | 21.1 | Additional activity | Pharmaceutical substances | | All types of activities | | 21.20 | Additional activity | Manufacturers of drugs and pharmaceuticals and medical products | | 46.18.1 | Additional activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents | | 46.19 | Additional activity | Activity of agents in wholesale trade of universal assortment of goods | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | 46.69 | Additional activity | Wholesale of other machinery and equipment | | 46.9 | Additional activity | Wholesale trade in specialized stores | | 62.0 | Additional activity | The development of computer software, consulting services in this area and other related services | | 63.11.1 | Additional activity | Data processing, hosting and related activities | | 73.20 | Additional activity | Market research and public opinion polling | | 82.99 | Additional activity | Other business support services to businesses and individuals not otherwise specified |
Registration date | 24.04.2012 |
|---|
|
SOLYUR-FARMA, OOO (Moscow; INN 7702788201) was registered on 24 Apr 2012. The company's authorized capital as of July 1, 2012 was 25000 rub. Principal activities of SOLYUR-FARMA, OOO: research and experimental development on natural sciences and engineering other (72.19), manufacture of perfumes and cosmetics (20.42), pharmaceutical substances (21.1). |
Economic indicators2023
Net profit (RAS) of SOLYUR-FARMA, OOO dropped in 2023 by 38.95% to 12.09 million RUB from 19.80 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 14.56% to 114.18 million RUB from 133.64 million RUB in 2022. 2022
Net profit (RAS) of SOLYUR-FARMA, OOO grew over 2022 1.57 times to 19.80 million RUB from 12.59 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 20.26% to 133.64 million RUB from 167.59 million RUB in 2021. 2021
Net profit (RAS) of SOLYUR-FARMA, OOO dropped in 2021 by 5.94% to 12.59 million RUB from 13.39 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 43.14% to 167.59 million RUB from 117.08 million RUB over 2020. 2020
Net profit (RAS) of SOLYUR-FARMA, OOO grew over 2020 2.60 times to 13.38 million RUB from 5.15 million RUB over 2019, the company informed. Revenue increased in the accounting period by 6.86% to 117.08 million RUB from 109.57 million RUB over 2019. 2019
Net profit (RAS) of SOLYUR-FARMA, OOO dropped in 2019 by 8.72% to 5.15 million RUB from 5.64 million RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 46.92% to 109.57 million RUB from 74.57 million RUB over 2018. 2018
Net profit (RAS) of SOLYUR-FARMA, OOO grew over 2018 3.28 times to 5.92 million RUB from 1.81 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 36.25% to 74.57 million RUB from 116.98 million RUB in 2017; cost of goods sold decreased by 36.61% to 70.37 million RUB from 111.01 million RUB; sales profit fell by 29.68% to 4.20 million RUB from 5.97 million RUB. 2017
Net profit (RAS) of SOLYUR-FARMA, OOO dropped in 2017 8.07 times to 1.81 million RUB from 14.58 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 30.97% to 116.98 million RUB from 89.32 million RUB over 2016; cost of goods sold grew 1.71 times to 111.01 million RUB from 65.00 million RUB; sales profit fell 4.07 times to 5.97 million RUB from 24.32 million RUB. 2016
Net profit (RAS) of SOLYUR-FARMA, OOO made up 21.48 million RUB over 2016 compared to net loss of 704.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period 1.67 times to 89.90 million RUB from 53.92 million RUB over 2015; cost of goods sold grew by 9.79% to 63.10 million RUB from 57.47 million RUB; sales profit made up 26.81 million RUB compared to sales loss of 3.56 million RUB. 2014
Net profit (RAS) of SOLYUR-FARMA, OOO grew over 2014 by 42.89% to 8.72 million RUB from 6.10 million RUB over 2013, the company informed. Revenue increased in the accounting period by 17.90% to 61.69 million RUB from 52.32 million RUB over 2013; cost of goods sold grew by 13.25% to 52.35 million RUB from 46.22 million RUB; sales profit went up 1.53 times to 9.35 million RUB from 6.10 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|